In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Buyback Our Safety Act''.

SEC. 2. GUN BUYBACK GRANT PROGRAM.

    (a) In General.--The Attorney General, through the Assistant 
Attorney General for the Office of Justice Programs of the Department 
of Justice, shall establish a gun buyback grant program under which the 
Assistant Attorney General may make grants to law enforcement agencies 
of States, units of local government, and Indian tribal governments to 
assist in funding gun buyback programs carried out by such agencies.
    (b) Gun Buyback Program Defined.--For purposes of this section, the 
term ``gun buyback program'' means, with respect to a law enforcement 
agency of a State, unit of local government, or Indian tribal 
government, a program carried out by such agency under which guns are 
purchased or surrendered to such agency.
    (c) Applications.--A law enforcement agency described in subsection 
(a) desiring a grant under this section shall submit to the Assistant 
Attorney General for the Office of Justice Programs an application for 
the grant, in accordance with subsection (d) and which shall be in such 
form and contain such information as the Assistant Attorney General may 
require.
    (d) Requirements.--The Assistant Attorney General may make a grant 
under this section to a law enforcement agency described in subsection 
(a), with respect to a gun buyback program, only if the application 
submitted under subsection (c) by such agency provides assurances 
that--
            (1) the law enforcement agency will adequately advertise 
        such program to the public;
            (2) such program will be administered by law enforcement 
        personnel;
            (3) all guns received through such program will remain in 
        the possession of law enforcement personnel;
            (4) adequate safeguards will be established and followed to 
        prevent the occurrence of fraud in such program;
            (5) the law enforcement agency will have in place a process 
        to test on site a gun purchased from an individual through such 
        program before payment is provided to such individual; and
            (6) an adequate process will be in place to destroy all 
        guns received through such program.
    (e) Matching Requirement.--
            (1) In general.--Subject to paragraph (2), to be eligible 
        for a grant under this section, a law enforcement agency must 
        certify that the law enforcement agency will match all Federal 
        funds provided under such grant with an equal amount of cash or 
        in-kind goods or services from other non-Federal sources.
            (2) Waiver.--The Assistant Attorney General for the Office 
        of Justice Programs may waive, wholly or in part, the matching 
        requirement under paragraph (1) with respect to a grant made 
        under this section to a law enforcement agency for a gun 
        buyback program if such program provides for obtaining only the 
        guns identified by the National Academy of Sciences pursuant to 
        subsection (f).
    (f) National Academy of Sciences Standards.--The Attorney General, 
through the Assistant Attorney General for the Office of Justice 
Programs, shall enter into an arrangement with the National Academy of 
Sciences to develop standards for identifying, and identify, guns that 
are the most likely to be used in violent crimes and establish a 
pricing scale for purchasing guns so identified through gun buyback 
programs receiving grants under this section.
    (g) Reports.--
            (1) Reports required by grantees.--In the case of a law 
        enforcement agency described in subsection (a) receiving a 
        grant under this section with respect to a gun buyback program, 
        such agency shall submit to the Assistant Attorney General for 
        the Office of Justice Programs--
                    (A) not later than 90 days after receipt of such 
                grant and every 90 days thereafter during the period 
                for which the program is carried out, a report 
                including--
                            (i) the number and types of guns collected 
                        and destroyed through such program during such 
                        period; and
                            (ii) recommendations for improving future 
                        gun buyback programs in the jurisdiction of 
                        such agency; and
                    (B) not later than 90 days after the last day of 
                such program, a final report including the information 
                described in each of subclauses (I) and (II) of clause 
                (i) with respect to the duration of the program.
            (2) Reports by the office of justice programs.--Not later 
        than one year after the date of the enactment of this section 
        and annually thereafter, the Assistant Attorney General for the 
        Office of Justice Programs shall submit to Congress a report 
        on--
                    (A) the number of gun buyback programs that 
                received funding under this section;
                    (B) the number of guns received through each such 
                gun buyback program;
                    (C) the total number of guns purchased through all 
                such gun buyback programs; and
                    (D) recommendations on improving the grant program 
                under this section and gun buyback programs.
    (h) Definitions.--For purposes of this section:
            (1) State.--The term ``State'' means each of the 50 States, 
        the District of Columbia, the Commonwealth of Puerto Rico, the 
        United States Virgin Islands, American Samoa, Guam, and the 
        Northern Mariana Islands.
            (2) Unit of local government.--The term ``unit of local 
        government'' means a county, municipality, town, township, 
        village, parish, borough, or other unit of general government 
        below the State level.
            (3) Violent crime.--The term ``violent crime'' means 
        murder, non-negligent manslaughter, forcible rape, robbery, and 
        aggravated assault, as reported by the Federal Bureau of 
        Investigation for purposes of the Uniform Crime Report.
    (i) Authorization of Appropriations.--There are authorized to be 
appropriated to carry out this section $15,000,000 for the period of 
fiscal years 2018 through 2022.
[EX A]:   Buyback Our Safety Act This bill authorizes the Department of Justice's Office of Justice Programs (OJP) to establish a gun buyback grant program for state, local, and tribal law enforcement agencies. The OJP must enter into an arrangement with the National Academy of Sciences to develop standards to identify the guns likely to be used in violent crimes and to establish a pricing scale for guns purchased through a gun buyback program. 

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Meningococcal Vaccination Act of 
2004''.

SEC. 2. VACCINATION REQUIREMENTS.

    Part G of title IV of the Higher Education Act of 1965 is amended 
by inserting after section 485C (20 U.S.C. 1092c) the following new 
section:

``SEC. 485D. VACCINATION REQUIREMENTS.

    ``(a) Definitions.--As used in this section:
            ``(1) The term `enrolled' means having registered for a 
        credit or noncredit course.
            ``(2) The term `postsecondary institution' means a school 
        of post-secondary education that generally limits enrollment to 
        graduates of secondary schools and awards degrees at the 
        associate, baccalaureate, or graduate level.
            ``(3) The term `meningococcal vaccination' means receipt of 
        the vaccine protecting against at least the four serogroups of 
        A, C, Y, and W-135 of meningococcal disease within the 3 years 
        preceding the date on which the individual moves into on-campus 
        student housing.
            ``(4) The term `on-campus student housing' means housing 
        provided to individuals, regardless of the fee, that is owned, 
        rented, or contracted for and operated by a postsecondary 
        institution, or through written agreement, with an agent of the 
        postsecondary institution.
    ``(b) Required Meningococcal Vaccination.--Except as provided in 
subsection (c), an individual enrolled in a postsecondary institution 
living in on-campus student housing shall--
            ``(1) obtain a meningococcal vaccination; and
            ``(2) submit written documentation to the postsecondary 
        institution from a health care professional or clinic of 
        receipt of a meningococcal vaccination.
    ``(c) Notification of Required Meningococcal Vaccination.--A 
postsecondary institution shall--
            ``(1) inform an individual or the parent or guardian of an 
        individual younger than 18 years old of the requirement for 
        meningococcal vaccination at the time the individual--
                    ``(A) is accepted for admission to a postsecondary 
                institution; or
                    ``(B) registers for classes, if the individual is 
                not required to apply for admission before registering 
                for courses;
            ``(2) include notice of the requirement for meningococcal 
        vaccination in--
                    ``(A) admission acceptance information;
                    ``(B) student health-related information and 
                materials;
                    ``(C) resident life information and materials;
                    ``(D) the student handbook; and
                    ``(E) the college catalog; and
            ``(3) provide detailed information to an individual who 
        resides or may reside in on-campus student housing or the 
        parent or guardian of an individual younger than 18 years old 
        who resides or may reside in on-campus student housing 
        concerning--
                    ``(A) the risks associated with meningococcal 
                disease; and
                    ``(B) the availability and effectiveness of 
                meningococcal vaccine.
    ``(d) Exemption From Meningococcal Vaccination Requirement.--
            ``(1) Adults.--An individual 18 years old or older is 
        exempt from the meningococcal vaccination requirement under 
        section 3 if the individual presents to the postsecondary 
        institution a signed written waiver in the form required by 
        section 6 stating that the individual has--
                    ``(A) received and reviewed the information 
                specified in section 4; and
                    ``(B) chosen not to obtain the meningococcal 
                vaccination.
            ``(2) Minors.--An individual younger than 18 years old is 
        exempt from the meningococcal vaccination requirement under 
        section 3 if a signed written waiver in the form required by 
        section 6 is presented to the postsecondary institution on 
        behalf of the individual stating that a parent or guardian of 
        the individual has--
                    ``(A) received and reviewed the information 
                specified in section 4; and
                    ``(B) chosen not to have the individual obtain the 
                meningococcal vaccination.
    ``(e) Waiver Form.--
            ``(1) Adults.--A waiver form for an individual 18 years old 
        or older shall--
                    ``(A) state that the individual--
                            ``(i) is 18 years old or older;
                            ``(ii) has received and reviewed the 
                        information provided by the postsecondary 
                        institution on the risk of meningococcal 
                        disease and the availability and effectiveness 
                        of meningococcal vaccine; and
                            ``(iii) chooses to waive the receipt of 
                        meningococcal vaccine; and
                    ``(B) provide spaces for the--
                            ``(i) printed name of the individual;
                            ``(ii) signature of the individual; and
                            ``(iii) date.
            ``(2) Minors.--A waiver form for an individual younger than 
        18 years old shall--
                    ``(A) state that--
                            ``(i) the individual is younger than 18 
                        years old;
                            ``(ii) the parent or guardian of the 
                        individual has received and reviewed the 
                        information provided by the postsecondary 
                        institution on the risk of meningococcal 
                        disease and the availability and effectiveness 
                        of meningococcal vaccine; and
                            ``(iii) the parent or guardian of the 
                        individual chooses to waive the receipt of 
                        meningococcal vaccine for the individual; and
                    ``(B) provide spaces for the--
                            ``(i) printed name of the individual;
                            ``(ii) printed name of the parent or 
                        guardian;
                            ``(iii) signature of the parent or 
                        guardian; and
                            ``(iv) date.
    ``(f) Payment for Inoculation.--Nothing in this section shall be 
construed to require a postsecondary institution or a local public 
health agency to provide or pay for a meningococcal vaccination.''.
[EX A]: Meningococcal Vaccination Act of 2004 - Amends the Higher Education Act of 1965 to require entering students who will reside in on-campus housing at postsecondary institutions to have received meningococcal vaccinations.

[EX Q]: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Comprehensive TB Elimination Act of 
2018''.

SEC. 2. NATIONAL STRATEGY FOR COMBATING AND ELIMINATING TUBERCULOSIS.

    (a) In General.--Section 317E of the Public Health Service Act (42 
U.S.C. 247b-6) is amended--
            (1) in subsection (a)--
                    (A) by striking ``The Secretary'' and inserting the 
                following:
            ``(1) Grants.--The Secretary''; and
                    (B) by adding at the end the following:
            ``(2) Priority.--In making grants under this subsection, 
        the Secretary may give priority to awarding grants to State 
        health departments proposing to focus on the prevention, 
        control, and elimination of tuberculosis in high-risk 
        populations, including foreign-born, homeless, incarcerated, 
        HIV-tuberculosis coinfected, and medically underserved 
        populations.'';
            (2) in subsection (b)--
                    (A) in paragraph (3)--
                            (i) in subparagraph (C), by redesignating 
                        clauses (i) and (ii) as subclauses (I) and 
                        (II), respectively, and adjusting the margins 
                        accordingly; and
                            (ii) by redesignating subparagraphs (A) 
                        through (F) as clauses (i) through (vi), 
                        respectively, and adjusting the margins 
                        accordingly;
                    (B) by redesignating paragraphs (1) through (8) as 
                subparagraphs (A) through (H), respectively, and 
                adjusting the margins accordingly;
                    (C) in the matter preceding subparagraph (A), as so 
                redesignated, by striking ``With respect to'' and 
                inserting the following:
            ``(1) In general.--With respect to''; and
                    (D) by striking subparagraph (B), as so 
                redesignated, and inserting the following:
                    ``(B) Research, investigations, experiments, 
                demonstrations, and studies in the health sciences that 
                are related to--
                            ``(i) the development of new therapeutics, 
                        including vaccines and antimicrobial drugs, to 
                        prevent and treat tuberculosis;
                            ``(ii) novel therapeutics for special 
                        populations, including pediatric populations, 
                        immunosuppressed individuals, and pregnant 
                        women;
                            ``(iii) the development or testing of 
                        medical diagnostics to detect tuberculosis;
                            ``(iv) public health interventions to 
                        address the epidemiology, mechanisms, and 
                        pathogenesis of tuberculosis, such as directly 
                        observed therapy and non-pharmaceutical 
                        intervention;
                            ``(v) methods to enhance detection and 
                        response to outbreaks of tuberculosis, 
                        including multidrug resistant tuberculosis; and
                            ``(vi) other relevant research areas.'';
                    (E) in subparagraph (C), as so redesignated--
                            (i) by redesignating clause (vi), as so 
                        redesignated, as clause (vii);
                            (ii) in clause (v), as so redesignated, by 
                        striking ``; and'' and inserting ``;''; and
                            (iii) by inserting after clause (v), as so 
                        redesignated, the following:
                            ``(vi) the intensification of efforts to 
                        prevent, detect, and treat latent tuberculosis; 
                        and'';
                    (F) in subparagraph (D), as so redesignated, by 
                inserting before the period the following: ``, 
                including public awareness campaigns and development of 
                educational, risk, and media communications.'';
                    (G) in subparagraph (F), as so redesignated, by 
                striking ``paragraphs (1) through (4)'' and inserting 
                ``subparagraphs (A) through (D)''; and
                    (H) by adding at the end the following:
            ``(2) Selection.--In carrying out the activities described 
        in paragraph (1), the Secretary--
                    ``(A) is encouraged to give priority to 
                programmatically relevant research so that new tools 
                can be utilized in public health practice; and
                    ``(B) may seek input from the Biomedical Advanced 
                Research and Development Authority in identifying novel 
                candidates to utilize in the efforts under this 
                subsection to prevent, diagnose, and control 
                tuberculosis.'';
            (3) by redesignating subsections (c) through (h) as 
        subsections (d) through (i), respectively;
            (4) by inserting after subsection (b) the following--
    ``(c) Grants for Coordination of Programs and Services for 
Prevention, Diagnosis, and Treatment.--
            ``(1) Grants.--The Secretary, acting through the 
        Administrator of the Health Resources and Services 
        Administration, may award grants to State and local governments 
        and Federally qualified health centers for coordinating the 
        programs and services of such States, governments, and centers 
        to ensure timely and appropriate prevention, risk-based 
        screening, diagnosis, and treatment of latent and active 
        tuberculosis.
            ``(2) Definition.--In this subsection, the term `Federally 
        qualified health center' has the meaning given to such term in 
        section 1861(aa) of the Social Security Act.'';
            (5) in subsections (d), (e), and (f), as so redesignated, 
        by striking ``(a) or (b)'' each place it appears and inserting 
        ``(a), (b), or (c)'';
            (6) in subsection (g)(4), as so redesignated, by adding at 
        the end the following:
                    ``(C) Report to congress.--The Secretary is 
                encouraged to make the reports under subparagraph (A), 
                or other publications relevant to domestic tuberculosis 
                surveillance, publicly available on the Internet 
                website of the Centers for Disease Control and 
                Prevention and disseminate such information to 
                stakeholders.'';
            (7) in subsection (h), as so redesignated--
                    (A) in paragraph (1)--
                            (i) by striking ``research into new tools 
                        under subsection (b)(2)'' and inserting ``the 
                        research, investigations, experiments, 
                        demonstrations, and studies in health science 
                        under subsection (b)(1)(B)''; and
                            (ii) by inserting ``ensuring access to the 
                        products developed as a result of such 
                        research, investigations, experiments, 
                        demonstrations, and studies and'' after 
                        ``advice regarding''; and
                    (B) in paragraph (3)--
                            (i) by redesignating subparagraphs (D) and 
                        (E) as subparagraphs (E) and (F), respectively; 
                        and
                            (ii) by inserting after subparagraph (C) 
                        the following:
                    ``(D) members of the Biomedical Advanced Research 
                and Development Authority;''; and
            (8) in subsection (i)(1)(A), as so redesignated, by 
        striking ``$200,000,000'' and all that follows through the 
        period and inserting ``$142,200,000 for fiscal year 2018, 
        $195,700,000 for fiscal year 2019, $225,000,000 for fiscal year 
        2020, $236,250,000 for fiscal year 2021, $248,062,500 for 
        fiscal year 2022, and $260,465,625 for fiscal year 2023.''.
    (b) NIH Tuberculosis Activities.--Section 424C(b) of the Public 
Health Service Act (42 U.S.C. 285b-7c(b)) is amended by striking 
paragraph (1) and inserting the following:
            ``(1) enhancing basic, clinical, and operational research 
        on tuberculosis, including with respect to--
                    ``(A) drug-resistant tuberculosis;
                    ``(B) infection with tuberculosis and latency and 
                progression of tuberculosis; and
                    ``(C) pediatric tuberculosis;''.

SEC. 3. GAO STUDY.

    Not later than 2 years after the date of enactment of this Act, the 
Comptroller General of the United States shall issue a report on the 
coordination of efforts in the United States to--
            (1) prevent, control, and eliminate tuberculosis; and
            (2) implement the activities under section 317E of the 
        Public Health Service Act (42 U.S.C. 247b-6), as amended by 
        this Act, and the National Action Plan for Combating Multidrug-
        Resistant Tuberculosis, issued in December 2015.
[EX A]:
Comprehensive TB Elimination Act of 2018 This bill amends the Public Health Service Act to reauthorize for FY2018-FY2023 and revise the tuberculosis (TB) prevention and treatment grant program administered by the Centers for Disease Control and Prevention. The Health Resources and Services Administration may also award grants to state and local governments and federally-qualified health centers for TB prevention and treatment efforts.  Additionally, the Government Accountability Office must report on national TB prevention and treatment efforts.